Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network
- PMID: 21457681
- DOI: 10.4088/JCP.10m06090blu
Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network
Abstract
Background: Potential adverse effects of antidepressants during pregnancy have caused concern about their use. There are, however, very limited detailed data on patterns of antidepressant prescribing in pregnancy.
Objective: To examine secular trends in prescribing during pregnancy, to assess whether pregnancy is a major determinant for stopping antidepressants, and to identify characteristics of those who stopped antidepressants during pregnancy.
Method: In this cohort study, we obtained data on 114,999 pregnant women (median age at delivery, 30.5 years [interquartile range, 26-34 years]) who had a live birth between 1992 and 2006 and 22,677 nonpregnant women from The Health Improvement Network primary care database, one of the largest sources of continuous anonymized primary care data in the United Kingdom and broadly representative of UK general practice. This database includes information on age, sex, medical diagnosis and symptoms, health promotion activities, referrals to secondary care, and prescriptions for each registered individual. The database also holds information about social deprivation as measured using quintiles of the Townsend score. We used Cox regression analysis to compare time to last prescription in pregnant versus nonpregnant women and to identify characteristics of those women who stopped antidepressants during pregnancy.
Results: Antidepressant prescribing in pregnancy increased nearly 4-fold from 1992 to 2006 (relative risk = 3.87; 95% CI, 1.73-8.66; P < .001). Since 2001, approximately 3% of the cohort received antidepressants at some stage during pregnancy. Selective serotonin reuptake inhibitors accounted for approximately 80% of the prescribed antidepressants. Antidepressants were more likely to be stopped in pregnant than in nonpregnant women, in particular during the first 6 weeks of pregnancy (hazard ratio = 5.19; 95% CI, 4.85-5.56; P < .001). Only 10% of women treated before pregnancy still received antidepressants at the start of the third trimester. In contrast, 35% of nonpregnant women were still treated after a similar time period.
Conclusions: Although antidepressant prescribing in pregnancy increased nearly 4-fold from 1992 to 2006, pregnancy was a major determinant of cessation of antidepressant medication, and most women did not receive further antidepressant prescriptions beyond 6 weeks of gestation. This finding may be explained by concerns about potential adverse effects of the medications, even though these concerns need to be balanced against the potential harm of inadequate treatment of depression during pregnancy.
© Copyright 2011 Physicians Postgraduate Press, Inc.
Comment in
-
Antidepressant medication treatment during pregnancy: prevalence of use, clinical implications, and alternatives.J Clin Psychiatry. 2011 Jul;72(7):977-8. doi: 10.4088/JCP.11f07206. J Clin Psychiatry. 2011. PMID: 21824457 No abstract available.
Similar articles
-
Prevalence and sociodemographic patterns of antidepressant use among women of reproductive age: a prescription database study.J Affect Disord. 2014;167:299-305. doi: 10.1016/j.jad.2014.06.015. Epub 2014 Jun 19. J Affect Disord. 2014. PMID: 25005798
-
Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children.Health Technol Assess. 2023 Sep;27(15):1-83. doi: 10.3310/AQTF4490. Health Technol Assess. 2023. PMID: 37842916
-
The effect of regulatory advisories on maternal antidepressant prescribing, 1995-2007: an interrupted time series study of 228,876 pregnancies.Arch Womens Ment Health. 2014 Feb;17(1):17-26. doi: 10.1007/s00737-013-0383-6. Epub 2013 Oct 3. Arch Womens Ment Health. 2014. PMID: 24196827 Free PMC article.
-
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Encephale. 2010. PMID: 20513456 Review. French.
-
Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.Health Technol Assess. 2016 Mar;20(23):1-176. doi: 10.3310/hta20230. Health Technol Assess. 2016. PMID: 27029490 Free PMC article. Review.
Cited by
-
Concepts for selection and utilization of psychiatric medications in pregnancy.Ment Health Clin. 2023 Dec 1;13(6):255-267. doi: 10.9740/mhc.2023.12.255. eCollection 2023 Dec. Ment Health Clin. 2023. PMID: 38058594 Free PMC article.
-
General practitioner perceptions and experiences of managing perinatal mental health: a scoping review.BMC Pregnancy Childbirth. 2023 Dec 2;23(1):832. doi: 10.1186/s12884-023-06156-6. BMC Pregnancy Childbirth. 2023. PMID: 38042768 Free PMC article. Review.
-
Antidepressant treatment in pregnancy: a Danish registry linkage study in pregnant women with pre-existing obsessive-compulsive disorder.Transl Psychiatry. 2023 Jun 23;13(1):223. doi: 10.1038/s41398-023-02516-0. Transl Psychiatry. 2023. PMID: 37353477 Free PMC article.
-
Effect of Remote Peer-Counsellor- delivered Behavioral Activation and Peer-support for Antenatal Depression on Gestational Age at Delivery: a single-blind, randomized control trial.Trials. 2023 Mar 30;24(1):240. doi: 10.1186/s13063-023-07077-7. Trials. 2023. PMID: 36997966 Free PMC article. Clinical Trial.
-
Women's experiences of over-the-counter and prescription medication during pregnancy in the UK: findings from survey free-text responses and narrative interviews.BMJ Open. 2023 Mar 1;13(3):e067987. doi: 10.1136/bmjopen-2022-067987. BMJ Open. 2023. PMID: 36858469 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical